These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38885191)

  • 1. Enveloped Viral Replica Equipped with Spike Protein Derived from SARS-CoV-2.
    Furukawa H; Nakamura S; Mizuta R; Sakamoto K; Inaba H; Sawada SI; Sasaki Y; Akiyoshi K; Matsuura K
    ACS Synth Biol; 2024 Jul; 13(7):2029-2037. PubMed ID: 38885191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
    Jafary F; Jafari S; Ganjalikhany MR
    Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
    Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry.
    Luchini A; Micciulla S; Corucci G; Batchu KC; Santamaria A; Laux V; Darwish T; Russell RA; Thepaut M; Bally I; Fieschi F; Fragneto G
    Sci Rep; 2021 Jul; 11(1):14867. PubMed ID: 34290262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
    Ge J; Zhang S; Zhang L; Wang X
    Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
    Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
    Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
    Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
    Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
    Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor.
    Odolczyk N; Marzec E; Winiewska-Szajewska M; Poznański J; Zielenkiewicz P
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33918595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
    J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment.
    Li J; Xu D; Wang L; Zhang M; Zhang G; Li E; He S
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike.
    Wrobel AG
    Curr Opin Struct Biol; 2023 Aug; 81():102619. PubMed ID: 37285618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.
    Wang L; Xiang Y
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33187074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2.
    Hatmal MM; Alshaer W; Al-Hatamleh MAI; Hatmal M; Smadi O; Taha MO; Oweida AJ; Boer JC; Mohamud R; Plebanski M
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
    Li Z; Zhang JZH
    Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.